129 related articles for article (PubMed ID: 27765459)
1. Carboplatin-allergic patients undergoing desensitization: prevalence and impact of the BRCA 1/2 mutation.
Galvão VR; Phillips E; Giavina-Bianchi P; Castells MC
J Allergy Clin Immunol Pract; 2017; 5(3):816-818. PubMed ID: 27765459
[No Abstract] [Full Text] [Related]
2. Impact of carboplatin hypersensitivity and desensitization on patients with recurrent ovarian cancer.
Altwerger G; Florsheim EB; Menderes G; Black J; Schwab C; Gressel GM; Nelson WK; Carusillo N; Passante T; Huang G; Litkouhi B; Azodi M; Silasi DA; Santin A; Schwartz PE; Ratner ES
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2449-2456. PubMed ID: 30255380
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of Omalizumab in Rapid Drug Desensitization in Patients With Severe Anaphylaxis Induced by Carboplatin: Open Questions.
Sánchez-Morillas L; Casado Herráez A; Rubio-Perez M; Robledo Echarren T; González Gutiérrez ML; Cimarra M; Vázquez Cortés S; Cerecedo I; Fernández-Rivas M
J Investig Allergol Clin Immunol; 2020; 30(4):298-300. PubMed ID: 32101175
[No Abstract] [Full Text] [Related]
4. Efficacy of Therapeutic Plasma Exchange in Severe Immune Hemolytic Anemia Induced by a Carboplatin Desensitization Procedure.
Vilà-Nadal G; Fiandor Román A; Heredia Revuelto R; Hernández-Maraver D; Kerguelen Fuentes AE; Ramírez García E; Cabañas Moreno R
J Investig Allergol Clin Immunol; 2021 Apr; 31(2):178-179. PubMed ID: 32732185
[No Abstract] [Full Text] [Related]
5. Management of hypersensitivity reactions to Carboplatin and Paclitaxel in an outpatient oncology infusion center: a 5-year review.
Banerji A; Lax T; Guyer A; Hurwitz S; Camargo CA; Long AA
J Allergy Clin Immunol Pract; 2014; 2(4):428-33. PubMed ID: 25017531
[TBL] [Abstract][Full Text] [Related]
6. [Successful desensitization using cisplatin after carboplatin-associated hypersensitivity reactions in 3 cases with recurrent ovarian carcinoma].
Hosaka M; Ebina Y; Moriwaki M; Hara Y; Araki N; Todo Y; Takeda M; Watari H; Sakuragi N
Gan To Kagaku Ryoho; 2007 Sep; 34(9):1505-8. PubMed ID: 17876157
[TBL] [Abstract][Full Text] [Related]
7. Carboplatin desensitization.
Keat K; Harnett P; Fulcher DA
Ann Allergy Asthma Immunol; 2007 Nov; 99(5):468-9. PubMed ID: 18051220
[No Abstract] [Full Text] [Related]
8. Initial experience with carboplatin desensitization: A case series in a paediatric hospital.
Rodríguez Del Río P; Andión M; Ruano D; Escudero C; Méndez Brea P; Sánchez-García S; Ibáñez MD
Pediatr Allergy Immunol; 2018 Feb; 29(1):111-115. PubMed ID: 28981992
[No Abstract] [Full Text] [Related]
9. [Tolerance induction in anaphylaxis to carboplatin].
Herzinger T; Behr J; Przybilla B
Dtsch Med Wochenschr; 2003 Jul; 128(30):1595-6. PubMed ID: 12884147
[No Abstract] [Full Text] [Related]
10. Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions.
Lee CW; Matulonis UA; Castells MC
Gynecol Oncol; 2004 Nov; 95(2):370-6. PubMed ID: 15491759
[TBL] [Abstract][Full Text] [Related]
11. Platinum desensitization in patients with carboplatin hypersensitivity: A single-institution retrospective study.
Altwerger G; Gressel GM; English DP; Nelson WK; Carusillo N; Silasi DA; Azodi M; Santin A; Schwartz PE; Ratner ES
Gynecol Oncol; 2017 Jan; 144(1):77-82. PubMed ID: 27789084
[TBL] [Abstract][Full Text] [Related]
12. Investigation of Hypersensitivity Reactions in Carboplatin Desensitization Therapy.
Shibata N; Kawakami K; Hisanori S; Kobayashi K; Yunokawa M; Kanao H; Taki I; Murase R; Kamei D; Yamaguchi M
Anticancer Res; 2022 Feb; 42(2):1091-1097. PubMed ID: 35093911
[TBL] [Abstract][Full Text] [Related]
13. Women's Health Issues for BRCA Mutation Carriers.
Sabatini ME; Ellisen LW
Am Soc Clin Oncol Educ Book; 2016; 35():14-7. PubMed ID: 27249681
[No Abstract] [Full Text] [Related]
14. Carboplatin hypersensitivity: does introduction of skin test and desensitization reliably predict and avoid the problem? A prospective single-center study.
Gomez R; Harter P; Lück HJ; Traut A; Kommoss S; Kandel M; du Bois A
Int J Gynecol Cancer; 2009 Oct; 19(7):1284-7. PubMed ID: 19823066
[TBL] [Abstract][Full Text] [Related]
15. Desensitization with oxaliplatin in patients intolerant of carboplatin desensitization.
Rose PG; Metz C; Link N
Int J Gynecol Cancer; 2014 Nov; 24(9):1603-6. PubMed ID: 25304679
[TBL] [Abstract][Full Text] [Related]
16. Successful carboplatin desensitization in patients with proven carboplatin allergy.
Confino-Cohen R; Fishman A; Altaras M; Goldberg A
Cancer; 2005 Aug; 104(3):640-3. PubMed ID: 15977213
[TBL] [Abstract][Full Text] [Related]
17. A modified, prolonged desensitization protocol in carboplatin allergy.
Goldberg A; Confino-Cohen R; Fishman A; Beyth Y; Altaras M
J Allergy Clin Immunol; 1996 Oct; 98(4):841-3. PubMed ID: 8876561
[No Abstract] [Full Text] [Related]
18. Successful rapid desensitization to intravenous bevacizumab using a 14-step protocol: Case report.
Williams SJ; Khokhar A; Gharib A
J Allergy Clin Immunol Pract; 2017; 5(6):1746-1747. PubMed ID: 28606785
[No Abstract] [Full Text] [Related]
19. Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management.
Hesterberg PE; Banerji A; Oren E; Penson RT; Krasner CN; Seiden MV; Wong JT
J Allergy Clin Immunol; 2009 Jun; 123(6):1262-7.e1. PubMed ID: 19501233
[TBL] [Abstract][Full Text] [Related]
20. Mutation spectrum and prevalence of BRCA1 and BRCA2 genes in patients with familial and early-onset breast/ovarian cancer from Tunisia.
Riahi A; Kharrat M; Ghourabi ME; Khomsi F; Gamoudi A; Lariani I; May AE; Rahal K; Chaabouni-Bouhamed H
Clin Genet; 2015 Feb; 87(2):155-60. PubMed ID: 24372583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
